Brief: Acasti Pharma Inc Received Written Notice From Nasdaq Notifying Co It Had Regained Compliance With Minimum Bid Price Requirement
July 24 (Reuters) - Acasti Pharma Inc ACST.O :
* ACASTI PHARMA INC - ON JULY 24 RECEIVED WRITTEN NOTICE
FROM
NASDAQ NOTIFYING CO IT HAD REGAINED COMPLIANCE WITH MINIMUM BID
PRICE REQUIREMENT
Further company coverage: ACST.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Grace Therapeutics
See all newsBrief: Grace Therapeutics - Selling Stockholders May Resell Up To 4,761,904 Shares Of Common Stock - SEC Filing
Grace Therapeutics Q1 net loss widens on impairment charges
Grace Therapeutics falls after FDA declines to approve stroke drug
NASDAQ RESUMED AT 01:57 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 01:52 PM